PROCTER & GAMBLE HEALTH | BAL PHARMA | PROCTER & GAMBLE HEALTH/ BAL PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 44.8 | 77.2% | View Chart |
P/BV | x | 10.6 | 2.5 | 425.1% | View Chart |
Dividend Yield | % | 2.0 | 1.0 | 201.4% |
PROCTER & GAMBLE HEALTH BAL PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
BAL PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ BAL PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 134 | 4,001.2% | |
Low | Rs | 3,883 | 63 | 6,124.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 193.9 | 382.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 1.7 | 8,281.4% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 7.5 | 2,072.3% | |
Dividends per share (Unadj.) | Rs | 95.00 | 1.00 | 9,500.0% | |
Avg Dividend yield | % | 2.1 | 1.0 | 202.9% | |
Book value per share (Unadj.) | Rs | 447.6 | 40.7 | 1,101.0% | |
Shares outstanding (eoy) | m | 16.60 | 15.69 | 105.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.5 | 1,225.7% | |
Avg P/E ratio | x | 33.5 | 59.2 | 56.5% | |
P/CF ratio (eoy) | x | 29.8 | 13.2 | 226.0% | |
Price / Book Value ratio | x | 10.3 | 2.4 | 425.3% | |
Dividend payout | % | 68.7 | 59.9 | 114.7% | |
Avg Mkt Cap | Rs m | 76,761 | 1,549 | 4,954.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 553 | 372.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 3,042 | 404.2% | |
Other income | Rs m | 184 | 9 | 1,954.3% | |
Total revenues | Rs m | 12,480 | 3,052 | 409.0% | |
Gross profit | Rs m | 3,247 | 253 | 1,285.9% | |
Depreciation | Rs m | 281 | 91 | 307.8% | |
Interest | Rs m | 8 | 123 | 6.3% | |
Profit before tax | Rs m | 3,142 | 47 | 6,616.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 21 | 3,979.8% | |
Profit after tax | Rs m | 2,295 | 26 | 8,761.7% | |
Gross profit margin | % | 26.4 | 8.3 | 318.1% | |
Effective tax rate | % | 27.0 | 44.8 | 60.1% | |
Net profit margin | % | 18.7 | 0.9 | 2,167.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 2,282 | 513.4% | |
Current liabilities | Rs m | 6,791 | 2,093 | 324.4% | |
Net working cap to sales | % | 40.0 | 6.2 | 647.0% | |
Current ratio | x | 1.7 | 1.1 | 158.3% | |
Inventory Days | Days | 263 | 8 | 3,430.0% | |
Debtors Days | Days | 343 | 1,128 | 30.5% | |
Net fixed assets | Rs m | 10,617 | 829 | 1,281.5% | |
Share capital | Rs m | 166 | 157 | 105.8% | |
"Free" reserves | Rs m | 7,265 | 481 | 1,510.3% | |
Net worth | Rs m | 7,431 | 638 | 1,164.9% | |
Long term debt | Rs m | 0 | 305 | 0.0% | |
Total assets | Rs m | 22,330 | 3,110 | 718.0% | |
Interest coverage | x | 409.1 | 1.4 | 29,522.1% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.0 | 56.3% | |
Return on assets | % | 10.3 | 4.8 | 214.7% | |
Return on equity | % | 30.9 | 4.1 | 752.1% | |
Return on capital | % | 42.4 | 18.1 | 234.3% | |
Exports to sales | % | 0 | 66.4 | 0.0% | |
Imports to sales | % | 13.1 | 22.4 | 58.2% | |
Exports (fob) | Rs m | NA | 2,020 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 683 | 235.2% | |
Fx inflow | Rs m | 1,465 | 2,020 | 72.5% | |
Fx outflow | Rs m | 1,605 | 716 | 224.3% | |
Net fx | Rs m | -140 | 1,305 | -10.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -18 | -12,798.3% | |
From Investments | Rs m | -215 | -222 | 96.9% | |
From Financial Activity | Rs m | -985 | 244 | -403.6% | |
Net Cashflow | Rs m | 1,160 | 4 | 31,024.1% |
Indian Promoters | % | 0.0 | 47.1 | - | |
Foreign collaborators | % | 51.8 | 4.2 | 1,248.7% | |
Indian inst/Mut Fund | % | 20.0 | 0.1 | 15,361.5% | |
FIIs | % | 6.2 | 0.1 | 4,800.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 48.8 | 98.8% | |
Shareholders | 56,778 | 14,772 | 384.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | BAL PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 1.96% | 0.45% |
1-Month | -1.15% | 1.50% | 2.55% |
1-Year | 0.73% | 27.08% | 56.14% |
3-Year CAGR | -8.76% | -4.23% | 15.22% |
5-Year CAGR | 4.97% | 6.90% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the BAL PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of BAL PHARMA the stake stands at 51.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of BAL PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
BAL PHARMA paid Rs 1.0, and its dividend payout ratio stood at 59.9%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of BAL PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.